Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | EVP and Chief Medical Officer | April 01, 2022 | April 05, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date April 01, 2022 · Filed April 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 232,676.059 |
Ending reported balance
After 2022-04-03 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-04-01 · Tax withholding · Disposed 77,960 · Balance 234,855.059 F1: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2022. Row 2 · 2022-04-03 · Tax withholding · Disposed 2,179 · Balance 232,676.059 F2: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award under the Registrant's 2017 Incentive Compensation Plan. |
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 4,805 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 4,805 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $104.82 · Expires 2023-04-01 | Direct | 53,772 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 53,772 F3: Option became exercisable in four equal annual installments, commencing 4/1/2017. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $78.05 · Expires 2024-04-03 | Direct | 75,134 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 75,134 F4: Option became exercisable in four equal annual installments, commencing 4/3/2018. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $62.21 · Expires 2025-04-01 | Direct | 21,894 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 21,894 F5: Option became exercisable in four equal annual installments, commencing 4/1/2019. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $54.19 · Expires 2029-04-01 | Direct | 80,803 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 80,803 F6: Option became exercisable in four equal annual installments, commencing 4/1/2020. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $58.34 · Expires 2030-04-01 | Direct | 84,478 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 84,478 F7: The number of shares subject to the option were calculated using a 30-day average price. F8: Options became exercisable in four equal annual installments, commencing 4/1/2021. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $74.30 · Expires 2031-04-01 | Direct | 99,344 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 99,344 F9: Option becomes exercisable in four equal annual installments, commencing 4/1/2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2022.
F2: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award under the Registrant's 2017 Incentive Compensation Plan.
F3: Option became exercisable in four equal annual installments, commencing 4/1/2017.
F4: Option became exercisable in four equal annual installments, commencing 4/3/2018.
F5: Option became exercisable in four equal annual installments, commencing 4/1/2019.
F6: Option became exercisable in four equal annual installments, commencing 4/1/2020.
F7: The number of shares subject to the option were calculated using a 30-day average price.
F8: Options became exercisable in four equal annual installments, commencing 4/1/2021.
F9: Option becomes exercisable in four equal annual installments, commencing 4/1/2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2022 Filed Apr 5, 2022 23:36 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 2,179 | $101.09 | $220,275.11 |
DisclosureSEC source: 0001127602-22-011639 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,676.059 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award under the Registrant's 2017 Incentive Compensation Plan. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 23:36 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 77,960 | $101.09 | $7,880,976.40 |
DisclosureSEC source: 0001127602-22-011639 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,855.059 F1 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2022. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 21:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 171,944 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006283 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,815.059 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 21:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 47,937 | $0.00 Strike: $102.26 | $0.00 |
DisclosureSEC source: 0001127602-22-003406 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 47,937 shares Expires 2022-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 21:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 47,937 | $110.00 | $5,273,070.00 |
DisclosureSEC source: 0001127602-22-003406 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,246.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 21:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 47,937 | $102.26 | $4,902,037.62 |
DisclosureSEC source: 0001127602-22-003406 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,183.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 28,159 | $0.00 Strike: $58.34 | $0.00 |
DisclosureSEC source: 0001127602-21-028310 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,478 Underlying: Common Stock · 28,159 shares Expires 2030-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The number of shares subject to the option were calculated using a 30-day average price. F2 · derivative.exercise_date: Options became exercisable in four equal annual installments, commencing 4/1/2021. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 28,159 | $90.00 | $2,534,310.00 |
DisclosureSEC source: 0001127602-21-028310 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,246.059 Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:44 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 28,159 | $58.34 | $1,642,796.06 |
DisclosureSEC source: 0001127602-21-028310 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,405.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 26, 2021 Filed Oct 28, 2021 20:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 80,802 | $0.00 Strike: $54.19 | $0.00 |
DisclosureSEC source: 0001127602-21-027755 · form4.xml · derivative · entry 5 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,803 Underlying: Common Stock · 80,802 shares Expires 2029-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2020. Read SEC document |
| October 26, 2021 Filed Oct 28, 2021 20:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 80,802 | $88.00 | $7,110,576.00 |
DisclosureSEC source: 0001127602-21-027755 · form4.xml · nonDerivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,246.059 F1 · deemedExecutionDate: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| October 26, 2021 Filed Oct 28, 2021 20:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 1,955 | $88.00 | $172,040.00 |
DisclosureSEC source: 0001127602-21-027755 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,048.059 Read SEC document |
| October 26, 2021 Filed Oct 28, 2021 20:34 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 80,802 | $54.19 | $4,378,660.38 |
DisclosureSEC source: 0001127602-21-027755 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,003.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 23:57 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 2,625 | $87.00 | $228,375.00 |
DisclosureSEC source: 0000947871-21-000985 · ownership.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,201.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 21:04 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 65,681 | $0.00 Strike: $62.21 | $0.00 |
DisclosureSEC source: 0001127602-21-020199 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,894 Underlying: Common Stock · 65,681 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2019. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 21:04 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 67,552 | $86.00 | $5,809,472.00 |
DisclosureSEC source: 0001127602-21-020199 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,826.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 21:04 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 65,681 | $62.21 | $4,086,015.01 |
DisclosureSEC source: 0001127602-21-020199 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,378.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2021 Filed May 10, 2021 21:18 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 9,477 | $84.00 | $796,068.00 |
DisclosureSEC source: 0001127602-21-016099 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,697.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 20:59 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 99,344 | $74.30 Strike: $74.30 | $7,381,259.20 |
DisclosureSEC source: 0001127602-21-012693 · form4.xml · derivative · entry 5 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,344 Underlying: Common Stock · 99,344 shares Expires 2031-04-01 F4 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2022. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 20:59 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,623 | $74.30 | $120,588.90 |
DisclosureSEC source: 0001127602-21-012693 · form4.xml · nonDerivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,174.059 F3 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 20:59 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 42,855 | $74.30 | $3,184,126.50 |
DisclosureSEC source: 0001127602-21-012693 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,219.059 F2 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021. Read SEC document |
| February 01, 2021 Filed Apr 2, 2021 20:59 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 94,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-012693 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,074.059 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 22:41 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 54,550 | $0.00 Strike: $74.29 | $0.00 |
DisclosureSEC source: 0001127602-21-001521 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54,550 shares Expires 2021-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2015. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 22:41 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 54,550 | $74.29 | $4,052,519.50 |
DisclosureSEC source: 0001127602-21-001521 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,558.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 22:41 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 58,896 | $75.00 | $4,417,200.00 |
DisclosureSEC source: 0001127602-21-001521 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,008.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 03, 2020 Filed Apr 7, 2020 21:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 2,179 | $55.72 | $121,413.88 |
DisclosureSEC source: 0001127602-20-013422 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,904.059 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:28 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 112,637 | $58.61 Strike: $58.61 | $6,601,654.57 |
DisclosureSEC source: 0001127602-20-013232 · form4.xml · derivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,637 Underlying: Common Stock · 112,637 shares Expires 2030-04-01 F2 · derivative.exercise_price: The number of shares subject to the option were calculated using a 30-day average price. F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2021. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:28 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,552 | $58.34 | $90,543.68 |
DisclosureSEC source: 0001127602-20-013232 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,279.059 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| April 01, 2020 Filed Apr 7, 2020 21:37 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 112,637 | $0.00 Strike: $58.34 | $0.00 |
DisclosureSEC source: 0001127602-20-013407 · form4a.xml · derivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,637 Underlying: Common Stock · 112,637 shares Expires 2030-04-01 F1 · derivative.exercise_price: This Form 4/A is being filed in order to correct the exercise price (Table II, column 2) for the stock option granted on 4/1/2020, which was reported incorrectly on the original Form 4 due to a clerical error. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:37 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 9,255 | $59.18 | $547,710.90 |
DisclosureSEC source: 0001127602-20-009159 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,408.059 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of stock awards under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:37 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 25,346 | $59.18 | $1,499,976.28 |
DisclosureSEC source: 0001127602-20-009159 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,663.059 F1 · shares: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 23,604 | $0.00 Strike: $54.53 | $0.00 |
DisclosureSEC source: 0001127602-19-032037 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,604 shares Expires 2020-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 23,604 | $68.00 | $1,605,072.00 |
DisclosureSEC source: 0001127602-19-032037 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,317.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 23,604 | $54.53 | $1,287,126.12 |
DisclosureSEC source: 0001127602-19-032037 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,921.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 161,605 | $54.19 Strike: $54.19 | $8,757,374.95 |
DisclosureSEC source: 0001127602-19-014669 · form4.xml · derivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,605 Underlying: Common Stock · 161,605 shares Expires 2029-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2020. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 3,606 | $54.19 | $195,409.14 |
DisclosureSEC source: 0001127602-19-014669 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,317.059 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under an incentive compensation plan. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 4,114 | $57.83 | $237,912.62 |
DisclosureSEC source: 0001127602-19-009280 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,857.059 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 9,477 | $57.83 | $548,054.91 |
DisclosureSEC source: 0001127602-19-009280 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,971.059 F1 · shares: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| November 14, 2018 Filed Nov 16, 2018 21:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 14,229 | $82.00 | $1,166,778.00 |
DisclosureSEC source: 0001127602-18-033414 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,494.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 01, 2018 Filed Apr 3, 2018 21:38 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 87,575 | $62.21 Strike: $62.21 | $5,448,040.75 |
DisclosureSEC source: 0001127602-18-013834 · form4.xml · derivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,575 Underlying: Common Stock · 87,575 shares Expires 2025-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2019. Read SEC document |
| April 01, 2018 Filed Apr 3, 2018 21:38 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 4,047 | $62.21 | $251,763.87 |
DisclosureSEC source: 0001127602-18-013834 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,723.059 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under an incentive compensation plan. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 21:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 1,208 | $67.73 | $81,817.84 |
DisclosureSEC source: 0001127602-18-009718 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,846.059 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under the Registrant's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 21:56 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 3,986 | $67.73 | $269,971.78 |
DisclosureSEC source: 0001127602-18-009718 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,054.059 F1 · shares: Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:40 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 75,134 | $78.05 Strike: $78.05 | $5,864,208.70 |
DisclosureSEC source: 0001127602-17-014059 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,134 Underlying: Common Stock · 75,134 shares Expires 2024-04-03 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:40 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 9,609 | $78.05 | $749,982.45 |
DisclosureSEC source: 0001127602-17-014059 · form4.xml · nonDerivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,486 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022. Read SEC document |
| April 02, 2017 Filed Apr 4, 2017 21:40 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 3,990 | $78.50 | $313,215.00 |
DisclosureSEC source: 0001127602-17-014059 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,068.059 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 21:40 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 2,097 | $78.50 | $164,614.50 |
DisclosureSEC source: 0001127602-17-014059 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,058.059 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| March 21, 2017 Filed Mar 22, 2017 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 16,637 | $0.00 Strike: $45.07 | $0.00 |
DisclosureSEC source: 0001127602-17-012624 · form4.xml · derivative · entry 5 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,637 shares Expires 2019-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| March 21, 2017 Filed Mar 22, 2017 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 7,212 | $78.73 | $567,800.76 |
DisclosureSEC source: 0001127602-17-012624 · form4.xml · nonDerivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,460.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $78.32 and $79.00 per share. Read SEC document |
| March 21, 2017 Filed Mar 22, 2017 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 16,637 | $78.73 | $1,309,831.01 |
DisclosureSEC source: 0001127602-17-012624 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,672.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $78.30 and $79.00 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.